Rate Notice: 5.9% general rate increase Jan 1, 2026 — Learn More
    Laurus Generics Inc logo depicts a stylized laurel wreath encircling the company name in a modern sansserif typeface

    Laurus Generics Inc.

    Laurus Generics Inc. is a US-based subsidiary of Laurus Labs, specializing in the development, manufacturing, and distribution of high-quality generic pharmaceuticals, with a focus on APIs and finished formulations for major therapeutic areas.

    Company Overview

    Laurus Generics Inc. operates as the US arm of Laurus Labs, a leading Indian multinational pharmaceutical company. The company is vertically integrated, offering active pharmaceutical ingredients (APIs) and finished dosage formulations, particularly for HIV, diabetes, cardiovascular, and central nervous system therapies. With state-of-the-art R&D and manufacturing capabilities, Laurus Generics Inc. serves global pharmaceutical markets, leveraging its parent company’s extensive expertise and regulatory approvals.

    Key Metrics

    400

    Import Shipments

    3

    Distribution Centers

    650.0M

    Annual Revenue

    2005

    Founded

    Company Profile

    Key Milestones

    Important company milestones and achievements.

    Markets Served

    Geographic markets and customer segments served.

    Ownership Structure

    Corporate ownership and organizational structure.

    Sales Channels

    Distribution networks and sales approaches.

    Recent Developments

    Laurus Generics Inc. is likely focused on expanding its US product portfolio, enhancing supply chain resilience, and investing in advanced manufacturing technologies to meet evolving regulatory and market demands.

    Strategic Expansion

    Expansion of R&D capabilities to accelerate new generic drug development

    Market Expansion

    Strategic efforts to expand market presence and reach new customer segments.

    Technology Adoption

    Implementation of advanced technologies to improve service delivery and customer experience.

    Business Information

    Laurus Generics Inc. delivers a comprehensive portfolio of generic pharmaceuticals, backed by in-house API manufacturing and advanced R&D. The company’s operations are supported by Laurus Labs’ global infrastructure, including multiple manufacturing sites in India and a strong regulatory track record. Laurus Generics Inc. focuses on supplying affordable, high-quality medicines to the US and international markets, with a particular emphasis on therapies for HIV, diabetes, cardiovascular, and CNS conditions. Their vertically integrated model ensures quality, supply chain reliability, and competitive pricing.

    Headquarters

    New Jersey, United States

    Founded

    2005

    Stock Symbol

    Private company